Cyclin D1 expression in dysplastic nevi: An immunohistochemical study

Archives of Pathology and Laboratory Medicine

Volumn 125, Issue 2, 2001, Pages 208-210

  Ewanowich, C ^a   Brynes, R K ^a   Medeiros, L J ^a   McCourty, A ^a   Lai, R ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL MATURATION; CELLULAR DISTRIBUTION; CHROMOSOME 11; CONTROLLED STUDY; DYSPLASTIC NEVUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

CHROMOSOMES, HUMAN, PAIR 11; CYCLIN D1; DYSPLASTIC NEVUS SYNDROME; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MELANOCYTES; TISSUE DISTRIBUTION;

EID: 0035116389     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. The retinoblastoma protein as a transcriptional repressor
2. The E2F transcription factors: Key regulators of cell proliferation
3. Genetic alterations of cyclins, cyclin-dependent kinases, and cdk inhibitors in human cancer
4. A cell cycle regulator potentially involved in genetics of many tumor types
5. INK4a and p53 genes in sporadic dysplastic nevus
6. Cyclin D1 over-expression in Spitz nevi: An immunohistochemical study
7. Reliability of the histopathologic diagnosis of melanocytic dysplasia
8. Demonstration of cyclin D1 (bcl-1) in mantle cell lymphoma: Enhanced staining using heat and ultrasound epitope retrieval
9. Cyclin D1 expression in renal cell carcinomas and oncocytomas: An immunohistochemical study
10. Cell kinetics of melanocytes in common and dysplastic nevi and in primary and metastatic cutaneous melanoma
11. Image analysis cytometry of dysplastic nevi
12. Nucleolar organizer regions (AgNOR) and Ki-67 immunoreactivity in cutaneous melanocytic lesions
13. Melanocytic atypia in dysplastic nevi: Immunohistochemical and cytophotometrical analysis
14. Analysis of melanocytic lesion by DNA image cytometry
15. The early and intermediate precursor lesions of tumor progression in the melanocytic system: Common acquired nevi and atypical (dysplastic nevi)